Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Neonc Technologies, Inc.
Var2 Pharmaceuticals
Vanderbilt University Medical Center
LigaChem Biosciences, Inc.
Vanderbilt-Ingram Cancer Center